top

  Info

  • Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.

  Info

  • Utilizzare questo link per rimuovere la selezione effettuata.
Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials
Nucleic Acid Architectures for Therapeutics, Diagnostics, Devices and Materials
Autore Afonin Kirill
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (186 p.)
Soggetto non controllato cotranscriptional folding
RNA
conditionally activated
i-motif DNA
spinal cord tumor
fluorescence
dynamic
stability
functional RNA
ribozyme
biological media
RNA aptamers
gene therapy
biosensors
viral vector
ganciclovir
RNA self-assembly
RNA nanoparticle
gene delivery
riboswitch
non-viral gene delivery
NANPs
silver nanoclusters
small-angle neutron scattering
contrast variation
aptamers
RNA logic
fluorogenic RNA
glioblastoma multiforme
RNA interference
nucleic acid nanoparticles
immunostimulation
aggregation
small-angle X-ray scattering
non-viral vector
light-up aptamer
nucleic acid therapeutic
live-cell imaging
DNA nanotechnology
nucleic acid computing
nanopores
structural characterization
siRNA
suicide gene therapy
nucleic acid nanoparticle
cytosine rich sequences
RNA nanotechnology
logic gates
serum
conditional activation
ISBN 3-03921-260-5
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367569503321
Afonin Kirill  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
The Application of Viruses to Biotechnology
The Application of Viruses to Biotechnology
Autore Varanda Carla
Pubbl/distr/stampa Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Descrizione fisica 1 electronic resource (296 p.)
Soggetto topico Technology: general issues
Soggetto non controllato Bacteriophage
Salmonella
biocontrol
comparative genomics
phage diversity
grapevine
apple latent spherical virus vector
virus-induced flowering
reduced generation time
breeding of grapevine
virus elimination
Newcastle disease virus
reverse genetics
vaccines
infectious diseases
cancer
porcine epidemic diarrhea virus
VLP
chemokines
pig
vaccine
SARS-CoV-2
COVID-19
phages
CRISPR
viruses
prevention
diagnosis
treatment
adeno-associated virus (AAV) vector
jaagsiekte sheep retrovirus (JSRV)
LTR
enhancer
transduction
viral vaccines
cancers
COVID-19 vaccines
self-replicating RNA vectors
DNA-based vaccines
RNA-based vaccines
plant virus
viroid
viral vector
virus-induced gene silencing (VIGS)
CRISPR/Cas9
genome editing
carotenoid biosynthesis
circular RNA
infectious bursal disease virus
immunization
recombinant Lactococcus lactis
variant strain
baculovirus
insect cells
bacmid
Tn7
genome stability
protein expression
chikungunya virus
VLPs
bioreactor
CRISPR/Cas systems
viral vectors
gene editing
plant genome engineering
viral resistance
adeno-associated virus
AAV
cancer gene therapy
prophage
hydrothermal vent
Hypnocyclicus thermotrophus
lytic cassette
Escherichia coli
heterologous expression
codon optimization
codon harmonization
expression vectors
aspect ratio
VNPs
TMV
PVX
CPMV
geminivirus
theranostics
CRISPR-cas9
clodronate
macrophage
gene therapy
gene expression
nanotechnology
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910557363903321
Varanda Carla  
Basel, Switzerland, : MDPI - Multidisciplinary Digital Publishing Institute, 2021
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui
Towards Mechanism-based Treatments for Fragile X Syndrome
Towards Mechanism-based Treatments for Fragile X Syndrome
Autore Kumari Daman
Pubbl/distr/stampa MDPI - Multidisciplinary Digital Publishing Institute, 2019
Descrizione fisica 1 electronic resource (250 p.)
Soggetto non controllato lymphoblast
pluripotent stem cells
FMR1
Gene editing
X chromosome
Fmr1
epigenetic gene silencing
FMR1 gene
Fragile X syndrome 1
repeat instability
characteristics that have the greatest impact
DNA instability
working memory
language development
mosaicism
CRISPR 3
clinical trials
autism spectrum disorders
Fmr1 KO mouse
automated vocal analysis
base excision repair (BER)
inhibitory control
cerebral spinal fluid
iPSC
drug development
targeted treatments
molecular biomarkers
viral vector
avoidance
biomarker
set-shifting
early identification
expansion
anxiety
planning
voice of the person
mismatch repair (MMR)
gene reactivation
double-strand break repair (DSBR)
newborn screening
intellectual disability
processing speed
voice of the patient
fragile X syndrome
adeno-associated virus
neurodevelopmental disorders
histone methylation
Non-homologous end-joining (NHEJ)
ASD
Fxr2
Fragile X-associated Tremor/Ataxia Syndrome 2
Trinucleotide Repeat 4
CGG Repeat Expansion Disease
DNA methylation
contraction
fragile X mental retardation protein
RNA:DNA hybrid
behavior
developmental disorders
cognition
females
FMRP
Fragile X Syndrome
unstable repeat diseases
protein synthesis
brain
cognitive flexibility
treatment development
fibroblast
PRC2
transcription coupled repair (TCR)
best practices
attention
Fragile X
executive function
ISBN 3-03921-506-X
Formato Materiale a stampa
Livello bibliografico Monografia
Lingua di pubblicazione eng
Record Nr. UNINA-9910367759103321
Kumari Daman  
MDPI - Multidisciplinary Digital Publishing Institute, 2019
Materiale a stampa
Lo trovi qui: Univ. Federico II
Opac: Controlla la disponibilità qui